In re Blue Cross Blue Shield Antitrust Litigation (MDL No.: 2406)

26 F. Supp. 3d 1172, 2014 WL 2767360
CourtDistrict Court, N.D. Alabama
DecidedJune 18, 2014
DocketNo. 2:13-CV-20000-RDP
StatusPublished
Cited by6 cases

This text of 26 F. Supp. 3d 1172 (In re Blue Cross Blue Shield Antitrust Litigation (MDL No.: 2406)) is published on Counsel Stack Legal Research, covering District Court, N.D. Alabama primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re Blue Cross Blue Shield Antitrust Litigation (MDL No.: 2406), 26 F. Supp. 3d 1172, 2014 WL 2767360 (N.D. Ala. 2014).

Opinion

MEMORANDUM OPINION

R. DAVID PROCTOR, District Judge.

This matter is before the court on various Motions to Dismiss filed by Defendants. (Docs. # 107, 108, 110, 112-14, 116, 119, 121, 122, 125, and 135). On April 9, 2014, the court heard argument on certain aspects of the Motions to Dismiss with general application to Defendants and both categories of Plaintiffs. After careful review and with the benefit of oral argument, the court denies certain of the Motions to Dismiss without prejudice.

I. Introduction

This multidistrict litigation involves a series of allegations by two separate putative classes which seek to represent Blue [1180]*1180Cross/Blue Shield Providers and Subscribers, respectively, from across the country. The Provider and Subscriber Putative Classes have each filed Master Complaints in this litigation. Both complaints allege, among other things, that the Defendant Blue Cross/Blue. Shield Plans, which are independent companies, along with the Blue Cross Blue Shield Association, have engaged in a conspiracy to horizontally allocate geographic markets (“the BCBS Market Allocation Conspiracy”) by agreeing with each other to carve the United States into “service areas” in which only one designated Blue plan is permitted to sell health insurance to customers (ie., the Subscribers) and contract with healthcare professionals and entities1 (ie., the Providers). Plaintiffs allege that this practice is per se illegal under Section 1 of the Sherman Act.

Defendants have moved to dismiss the Master Complaints on a number of grounds. To be clear, this Memorandum Opinion does not address all of those arguments. Rather, this ruling is limited to Defendants’ contentions that Plaintiffs have failed to state a Sherman Act Section 1 claim, and, in any event, that their antitrust claims are barred, at least in part, by the McCarran-Ferguson Act and the Filed Rate Doctrine. The court also addresses, but makes no ruling upon, the parties’ arguments about personal jurisdiction and venue.

II. Plaintiffs’ Claims

The court will not attempt to discuss in detail all of the claims advanced by class counsel for the Providers and Subscribers in this litigation. However, it does provide a summary of Plaintiffs’ claims and Defendants’ motions to dismiss (or at least those arguments related to the issues discussed in this Memorandum Opinion) as background for the court’s disposition of these motions.

A. The Subscribers’ Claims

The Subscribers allege the existence of an ongoing conspiracy between and among the Individual Blue Plans (sometimes referred to as “the Blues” or “the Blue Plans”) and the Blue Cross and Blue Shield Association (“BCBSA” or “the Association”) to allocate markets in violation of the Sherman Act. Their Master Complaint seeks both injunctive relief and damages. In particular, the Subscribers seek damages consisting of the difference between the supra-competitive premiums that the Individual Blue Plans have charged and lower competitive premiums that the noncompeting Blue Plans have not charged as a result of this illegal conspiracy. (Doc. # 99-1 at ¶ 2). In support of their market allocation claims, the Subscribers allege, inter alia, that Defendants have agreed to do the following:

a. Prohibit individual Blue Plans from competing against each other using the Blue name by allocating territories among the individual Blues;
b. Limit individual Blue Plans from competing against each other, even when they are not using the Blue trade name, by mandating the percentage of their business that they may conduct under the Blue name, both inside and outside each Plan’s territory;
c. Restrict the right of any individual Blue Plan to be sold to a company that is not a member of BCBSA, thereby preventing' new entrants into the individual Blues’ markets;
[1181]*1181d. Place severe territorial limitations upon the individual Blue Plans’ ability to compete outside of their geographic areas, even when using their non-Blue brands; and/or
e. . Not to utilize non-Blue brands to compete with other individual Blue Plans.

(Doc. # 99-1 at ¶ 4). But for these and other illegal agreements not to compete with one another, the Subscribers contend Defendants could (and would) use their Blue brands and non-Blue brands to compete with each other throughout their Service Areas, which would result in greater competition and competitively priced premiums for the Subscribers. (Doc. # 99-1 at ¶¶ 5-7).

B. Providers’ Claims

Similar to the allegations made by the Subscribers, the Providers allege thát Defendants previously reached an explicit agreement to divide the United States into what they term “Service Areas” and then to allocate those geographic markets among the Blues, free of competition from one another. The Providers specifically allege that Defendants have created geographic markets and allocated those among themselves by agreeing not to compete with each other within those markets. The Providers further allege that, as a result of decreased competition due to the market allocation, they are paid much less by the Blues than they would be absent Defendants’ conspiratorial conduct. (Doc. # 86 at ¶¶ 4-6).

The Providers contend that the alleged BCBS Market Allocation Conspiracy is a per se violation of Section 1 of the Sherman Act.2

C. Defendants’ Motions

As noted above, Defendants’ motions to dismiss assert a number of theories. However, at the hearing held on April 9, 2014, the court heard argument limited to the following issues:

1. Whether Plaintiffs have adequately pled per se violations of Section 1 of the Sherman Act related to their horizontal market allocation claims;
2. Whether proper consideration of Defendants’ motions requires some factual development;
3. The effect, if any, of common law trademarks on Plaintiffs’ Section 1 market allocation claims;
4. Whether the Filed Rate Doctrine bars some of Plaintiffs’ claims;
5. Whether the McCarran-Ferguson Act bars Plaintiffs’ claims; and
6. What rule of law controls as to personal jurisdiction and/or venue issues raised by certain Defendants.

(Doc. # 187). Again, the court will not attempt to capture and restate Defendants’ arguments in their entirety. However, a summary of their arguments is provided below.

[1182]*1182First, Defendants argue that their alleged market allocation actually relates to a network of service areas that have existed for more than half a century, and which originally arose from common law trademark rights. Defendants also contend that their service agreements create a unique product because they allow Defendants to compete like a nationally integrated health insurer, while still preserving a focus on meeting the health insurance needs of their local communities.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Kabisch v. RealPage, Inc.
M.D. Tennessee, 2024
In re Anthem-Cigna Merger Litigation
Court of Chancery of Delaware, 2020
In re Blue Cross Blue Shield Antitrust Litig.
308 F. Supp. 3d 1241 (N.D. Alabama, 2018)
In re Blue Cross Blue Shield Antitrust Litigation
238 F. Supp. 3d 1313 (N.D. Alabama, 2017)
Procaps S.A. v. Patheon Inc.
36 F. Supp. 3d 1306 (S.D. Florida, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
26 F. Supp. 3d 1172, 2014 WL 2767360, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-blue-cross-blue-shield-antitrust-litigation-mdl-no-2406-alnd-2014.